Cai Lay Veterinary Pharmaceutical JSC (HNX: MKV)

Market Cap	47.50B
Revenue (ttm)	109.98B
Net Income (ttm)	7.38B
Shares Out	5.00M
EPS (ttm)	n/a
PE Ratio	6.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Average Volume	3,085
Open	9,500.00
Previous Close	9,600.00
Day's Range	9,500.00 - 9,500.00
52-Week Range	8,000.00 - 11,800.00
Beta	0.59
RSI	51.10
Earnings Date	Jan 19, 2025

About HNX: MKV

Cai Lay Veterinary Pharmaceutical Joint Stock Company manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina. The company offers veterinary medicine, aquatic medicine, and animal nutrition. It provides products for cattle, pig, chicken, duck, dog, cat, fish, and other species through distributors and agents. The company was formerly known as Cai Lay Livestock and Veterinary Pharmacy Company and changed its name to Cai Lay Veterinary Pharmaceutical Joint Stock Company. Cai Lay Veterinary Pharmaceutical Joint Stock ...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MKV

Financial Performance

In 2023, MKV's revenue was 110.91 billion, a decrease of -7.30% compared to the previous year's 119.63 billion. Earnings were 6.20 billion, an increase of 5.04%.